Caris Life Sciences, Inc.
Company Information
Industry Services-Medical Laboratories
SIC Code 8071
Entity Type operating
SEC Category Non-accelerated filerEmerging growth company
State of Incorporation TX
Business Address 750 W JOHN CARPENTER FREEWAY, IRVING, TX, 75039
Mailing Address 750 W JOHN CARPENTER FREEWAY, IRVING, TX, 75039
Phone (866) 771-8946
Fiscal Year End 1231
EIN 852077369
Financial Overview
FY2025
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 4 Insider stock transaction report | March 10, 2026 | View on SEC |
| 4 Insider stock transaction report | March 10, 2026 | View on SEC |
| 4 Insider stock transaction report | March 10, 2026 | View on SEC |
| 4 Insider stock transaction report | March 10, 2026 | View on SEC |
| 4 Insider stock transaction report | March 10, 2026 | View on SEC |
| 10-K Annual financial report | March 3, 2026 | View on SEC |
| 4 Insider stock transaction report | March 2, 2026 | View on SEC |
| 4 Insider stock transaction report | February 27, 2026 | View on SEC |
| 4 Insider stock transaction report | February 27, 2026 | View on SEC |
| 4 Insider stock transaction report | February 27, 2026 | View on SEC |
Annual Reports
10-K March 3, 2026
- Successfully completed IPO on June 20, 2025, raising $350 million in net proceeds.
- Achieved strong revenue growth of 35% in 2025, reaching $420 million, driven by both Molecular Profiling and Pharma R&D services.
Insider Trading
SELL 1 insiders
2 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 8071)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.